by In2Pharma | Oct 27, 2023 | News
Belgium On 16 October, the Belgian federal agency for medicines and health products (FAMHP) has introduced a new application for the effective management of marketing authorisation and vigilance dossiers. Data Tracking System (DTS) will replace 4 MeSeA applications:...
by In2Pharma | Sep 29, 2023 | News
Belgium The Belgian “National Medicines Verification System” (NMVS) is linked to the “European Alert Management System” (EAMS) via a “National Alert Management System” (NAMS) since 1 July 2023. Since there is now the possibility of...
by In2Pharma | Sep 27, 2023 | News
Europe The European Parliament has published their assessment report on the implementation and application of the Regulation on nutrition and health claims made on foods (EC) 1924/2006. Health claims and use of health claims on foods containing botanicals are at the...
by In2Pharma | Sep 27, 2023 | News
The Netherlands The board of the codes of conduct issued by the Foundation for the Code for Pharmaceutical Advertising (“the CGR”) and the Foundation for the Code of Conduct for Medical Devices (“the GMH”) have decided to further tighten their rules as of...
by In2Pharma | Aug 4, 2023 | News
Belgium The FAMHP will open a new web portal later this year for manufacturers based in Belgium who are subject to inspections in the context of a GMP certificate, manufacturing and import authorization (MIA), raw materials (AR 97), active ingredients (API) or...
